|
Originally published In Press as doi:10.1074/jbc.M102025200 on June 4, 2001
J. Biol. Chem., Vol. 276, Issue 32, 29833-29838, August 10, 2001
Functional Analyses of Bph-Tod Hybrid Dioxygenase, Which Exhibits
High Degradation Activity toward Trichloroethylene*
Tomohiro
Maeda,
Yukihiro
Takahashi,
Hikaru
Suenaga,
Akiko
Suyama,
Masatoshi
Goto, and
Kensuke
Furukawa
From the Department of Bioscience and Biotechnology, Faculty of
Agriculture, Kyushu University, Fukuoka 812-8581, Japan
Received for publication, March 6, 2001, and in revised form, May 31, 2001
 |
ABSTRACT |
Biphenyl dioxygenase (BphDox) in
Pseudomonas pseudoalcaligenes KF707 is a multicomponent
enzyme consisting of an iron-sulfur protein (ISP) that is composed of
(BphA1) and (BphA2) subunits, a ferredoxin
(FDBphA3), and a ferredoxin reductase
(FDRBphA4). A recombinant Escherichia coli
strain expressing hybrid Dox that had replaced BphA1 with TodC1 ( subunit of toluene dioxygenase (TolDox) of Pseudomonas
putida) exhibited high activity toward trichloroethylene (TCE)
(Furukawa, K., Hirose, J., Hayashida, S., and Nakamura, K. (1994)
J. Bacteriol. 176, 2121-2123). In this study, ISP, FD, and
FDR were purified and characterized. Reconstitution of the dioxygenase
components consisting of purified ISPTodC1BphA2,
FDBphA3, and FDRBphA4 exhibited oxygenation
activities toward biphenyl, toluene, and TCE. Native polyacrylamide gel
electrophoresis followed by the Ferguson plot analyses demonstrated
that ISPTodC1BphA2 and ISPBphA1A2 were present
as heterohexamers, whereas ISPTodC1C2 was present as a
heterotetramer. The molecular activity
(k0) of the hybrid Dox for TCE was 4.1 min 1, which is comparable to that of TolDox. The
Km value of the hybrid Dox for TCE was 130 µM, which was lower than 250 µM for TolDox.
These results suggest that the subunit of ISP is crucial for the
determination of substrate specificity and that the change in the subunit conformation of ISP from 2 2 to
3 3 results in the acquisition of higher
affinity to TCE, which may lead to high TCE degradation activity.
 |
INTRODUCTION |
Biphenyl dioxygenase
(BphDox)1 in
Pseudomonas pseudoalcaligenes KF707 catalyzes the
introduction of two atoms of molecular oxygen into biphenyl and some
polychlorinated biphenyls (PCB). BphDox is a multicomponent enzyme
encoded by the four genes, bphA1A2A3A4, where
bphA1 encodes an subunit (BphA1) of the terminal
dioxygenase (an iron-sulfur protein, ISPBph),
bphA2 encodes the subunit (BphA2) of
ISPBph, bphA3 encodes ferredoxin (BphA3,
FDBphA3), and bphA4 encodes ferredoxin reductase
(BphA4, FDRBphA4) (1). ISP requires mononuclear iron
(Fe2+), which is likely to be an active center for
catalysis and contains a Rieske [2Fe-2S] cluster for electron
transfer. Recently a classification has been proposed for these types
of ISP as a family of Rieske non-heme iron oxygenases (2). FD
and FDR act as an electron transfer system from NADH to reduce ISP.
Recent studies provided evidence that the subunit of
ISPBph plays a primary role in the determination of the
substrate specificity for PCB (3-8). Modified BphDox constructed by
subunit exchange (3), site-directed mutagenesis (4-6), DNA shuffling
(7), and random-priming recombinations (8) resulted in the dramatic
alterations in the enzyme activities, the substrate selectivities, and
the mode of oxygenation toward certain PCB congeners (9). It is also
true that some BphDox from various bacteria share structural
similarities to those of KF707, however, their substrate specificities
toward PCB are different (10).
Toluene dioxygenase (TolDox) in Pseudomonas putida F1
catalyzes the conversion of toluene to cis-toluene
dihydrodiol (11). Besides toluene, TolDox exhibits catalytic activity
toward benzene, biphenyl, naphthalene, and trichloroethylene (TCE). The
toluene catabolic tod operon is similar to the KF707
bph gene cluster in terms of gene organization and the
nucleotide sequence of the corresponding genes (1, 12). TolDox is a
multicomponent enzyme consisting of (TodC1) and (TodC2)
subunits of ISPTod, FD (TodB), and FDR (TodA). The
identities of the amino acid sequences between the corresponding
components of BphDox and TolDox are in the range of 53 to 65% (1,
12).
During the course of identifying the component responsible for the
substrate specificity of BphDox and TolDox, hybrid bph-tod gene clusters were constructed by replacing genes encoding the dioxygenase components from BphDox and TolDox. Among them, the recombinant Escherichia coli expressing the hybrid
todC1-bphA2A3A4 genes exhibited substrate specificity
similar to that of the original TolDox, but 3-fold higher activity
toward TCE than TolDox (13). Chloroethylenes such as TCE have been
recognized to be significant environmental pollutants in the soil,
groundwater, and atmosphere (14). These compounds have been shown to
persist over time in the environment and are suspected to be
carcinogenic (15). In the recent past, it has been shown that TCE can
be degraded with a variety of oxygenases such as methane monooxygenase
(16), toluene monooxygenase (17), ammonium monooxygenase (18), phenol hydroxylase (19), and TolDox (11) from aerobic bacteria. The mechanism
of TCE oxygenation by TolDox has been proposed by Li and Wackett (20).
TCE is converted to an iron-bound dioxygenated intermediate on the
enzyme surface, and the intermediate compound is rearranged to form
formate and HCl using H2O.
We now report the purification of the TodC1-BphA2 hybrid Dox and the
kinetic analyses toward chloroethylenes.
 |
EXPERIMENTAL PROCEDURES |
Bacterial Strains and Culture Conditions
E. coli JM109 was used for the general propagation of
the plasmids and for the expression of ISP. E. coli
BL21(DE3) was used for the expression of bphA3 and
bphA4. For the expression of bphA1A2 and
todC1BphA2, E. coli cells were grown at 37 °C
for 12 h in Luria-Bertani medium containing 0.1 mM
isopropyl- -D-galactopyranoside and a concentration, 50 µg/ml, of the appropriate antibiotics. For expressions of
todC1C2, bphA3, and bphA4, E. coli cells were grown at 30 °C for 24 h in the same medium
described above.
Plasmids for ISP Expression
pUC-A1A2 for the expression of ISPbphA1A2 was
constructed by inserting the XhoI DNA fragment containing
the bphA1A2 genes from pKTF18 ORF3 (1) into an
SalI site of pUC119. pUC-C1A2, for the expression of the
hybrid ISPTodC1BphA2, was constructed by removing the
PstI DNA fragment containing the bphA3A4BC from pJHF10 (3). pHSG-C1C2, for the expression of the
ISPTodC1C2, was constructed as follows: The
todC2 gene without the original Shine-Dalgarno sequence was
amplified by PCR using pJHF-C1C2 (21) as the template DNA. An
oligonucleotide corresponding to the 5' sequence of the
todC2 gene, 5'-AAGAATTCAACATGATGATTCAGCCAACA-3' (primer #1), was used as a forward primer, where the EcoRI
site is underlined. An oligonucleotide corresponding to the 3' sequence of the todC2 gene,
5'-AAAGGTACCCTAGAAGAAGAAACTGAGG-3' (primer #2), was used as
the reverse primer, where the KpnI site is underlined. The
amplified DNA, which had been digested with EcoRI and
KpnI, was inserted into the corresponding sites of
pBluescriptII SK+ (Stratagene) to generate pBlue-C2. A
BamHI/EcoRI DNA fragment containing the
todC1 and the Shine-Dalgarno sequence of the
bphA2 gene from pUC-C1A2 was inserted into the corresponding
sites of pBlue-C2 to construct pBlue-C1C2. pHSG-C1C2 was finally
constructed by replacing the pBluescriptII region of pBlue-C1C2 by
pHSG396 (Toyobo, Kyoto, Japan) at the BamHI and
KpnI sites.
Plasmids for FDBphA3 and FDRBphA4
Expression
To express FDBphA3, the bphA3 gene was
amplified by PCR using pJHF10 as the template DNA. An oligonucleotide
corresponding to the 5' sequence of the bphA3 gene,
5'-ATATCCATGGTTATGAAATTTACCAGAGTTTGTGAT-3' (primer #3), was
used as the forward primer, where the NcoI site is
underlined. An oligonucleotide corresponding to the 3' sequence of the
bphA3 gene, 5'-TTTCTCGAGTGGCGCCAGATACCCGGC-3'
(primer #4), was used as the reverse primer, where the XhoI
site is underlined. The amplified DNA fragment, which had been digested
with NcoI and XhoI, was inserted downstream of
the thioredoxin gene (TRX), the six-histidine tag (His-tag), and
upstream of the His-tag of pET32b (Novagen), yielding pET32-A3 (see
Table I below). To construct pUC-A4 for the expression of
FDRBphA4, site-directed mutagenesis was carried out to
introduce an NcoI site around the start codon of the
bphA4 gene. An oligonucleotide,
5'-GCGATGGTGTCGACCATGGCGCCAG-3', where the
mutated nucleotide is indicated in boldface letters and the site newly
introduced NcoI is underlined, was used as the mutagenic
primer. As a template DNA for site-directed mutagenesis, pUC-A3A4 was
constructed by digesting pJHFA3A4BC (21) with PpuMI and
subsequent self-ligation. The mutagenized plasmid, pUC-A3A4N, was
digested with NcoI and EcoRI, and the
bphA4 fragment was inserted downstream of the TRX and
His-tag of pET32b, generating pET32-A4. An XbaI/EcoRI DNA
fragment containing the bphA4 gene from pET32-A4 was
inserted into the corresponding site of pUC119 to generate pUC-A4. A
plasmid, pKY206, expressing the groELS gene (22) was provided by Y. Kawata (Tottori University) and was used to produce the
soluble FDRBphA4 fusion protein.
PCR
PCR was performed in a total volume of 50 µl that contained
the PCR buffer (Promega, Madison, WI), 100 µM dNTPs, 1 µM forward and reverse primers, 0.5 unit of
Taq DNA polymerase (Promega), and 50 ng of a template DNA.
PCR was carried out for 25 cycles under the following conditions:
denaturation, 94 °C for 1 min; primer annealing, 55 °C for 1.5 min; and primer extension, 72 °C for 1 min.
Protein Purification
ISP purification was carried out according to the method
described by Haddock and Gibson (23) with some modifications. All the
purification steps were carried out at 4 °C. Harvested recombinant E. coli cells were suspended in 50 mM MOPS
buffer, pH 7.0, containing 5% ethanol and 5% glycerol (MEG). Cells
were disrupted by a French pressure cell (Ohtake Seisakusho, Tokyo)
prior to centrifugation at 17,400 × g for 10 min. The
resultant viscous liquid was treated with 3% streptomycin sulfate for
30 min and centrifuged. The resulting supernatant was used as a crude
enzyme. The crude enzyme was applied to a Q-Sepharose FF column
(Amersham Pharmacia Biotech) equilibrated with MEG. The hybrid
ISPTodC1BphA2 as well as the parental
ISPBphA1A2 and ISPTodC1C2 were purified as follows.
ISPBphA1A2--
Proteins were eluted in stepwise
fashions with 0.1 M KCl and 0.2 M KCl in MEG. A
fraction showing ISP activity was eluted with 0.2 M KCl.
The active fraction that had added 2.0 M ammonium sulfate
was applied to a Butyl-Toyopearl 650M column (Tohsho, Tokyo, Japan)
equilibrated with 2.0 M ammonium sulfate in MEG, and the
proteins were stepwise eluted with 2.0, 1.0, and 0.5 M ammonium sulfate in MEG. The fraction showing the ISP activity was
eluted with 0.5 M ammonium sulfate and was dialyzed against 10 mM potassium phosphate buffer, pH 7.0 (KP). The
dialysate was applied to a column of hydroxylapatite (Bio-Rad)
equilibrated with KP, and the proteins were eluted in stepwise fashions
with 0.01, 0.1, and 0.25 M KP. ISPBphA1A2 was
eluted with 0.25 M KP.
ISPTodC1C2--
Proteins were eluted using a linear
gradient from 0.2 to 0.4 M KCl in MEG. The fraction showing
ISP activity was eluted with 0.3 M KCl. The fraction in the
added 1.0 M ammonium sulfate was applied to a
Butyl-Toyopearl 650M column equilibrated with 1.0 M
ammonium sulfate in MEG, and the proteins were stepwise eluted with
1.0, 0.75, and 0.5 M ammonium sulfate in MEG. The fraction showing ISP activity was eluted with 0.5 M ammonium
sulfate. The subsequent procedure for purification of the
ISPTodC1C2 was the same as described above for
ISPBphA1A2.
ISPTodC1BphA2--
Proteins were eluted in stepwise
fashions with 0.2 and 0.4 M KCl in MEG. A fraction showing
ISP activity was eluted with 0.4 M KCl. The subsequent
procedure for purification of the ISPTodC1BphA2 was the
same as described for ISPBphA1A2.
FDBphA3 Fusion Protein--
The crude enzyme was
prepared by extracting with 50 mM KP containing 10 mM imidazole, pH 7.0, instead of that with MEG. The crude enzyme was applied to a nickel-nitrilotriacetic acid-agarose column (Qiagen) equilibrated with 50 mM KP containing 10 mM imidazole, pH 7.0. The agarose gel was washed with 50 mM KP containing 50 mM imidazole and 0.3 M NaCl (washing buffer). The FDBphA3 fusion protein was eluted with 50 mM KP containing 0.2 M imidazole and 0.3 M NaCl.
FDRBphA4 Fusion Protein--
Purification of the
FDRBphA4 fusion protein was done using the same method for
FDBphA3 but changing the washing buffer to 50 mM KP containing 20 mM imidazole, 0.3 M NaCl, and 0.5% Triton X-100.
Enzyme Assay
An assay for dioxygenase activity was spectrophotometrically
done. A total test volume of 250 µl contained 50 mM MOPS
buffer, pH 7.0, 0.4 mM ferrous ammonium sulfate, 0.4 mM NADH, 5 mM biphenyl, 1 mg of cell-free
extracts containing dihydrodiol dehydrogenase, 2,3-dihydroxybiphenyl
dioxygenase, and enzyme components. Incubation was done with shaking at
30 °C for the appropriate time. The product catalyzed by dioxygenase
from biphenyl was further converted to a yellow compound,
2-hydroxy-6-oxo-6-phenylhexa-2,4-dienoic acid by the sequential actions
of dihydrodiol dehydrogenase and 2,3-dihydroxybiphenyl dioxygenase. The
yellow compound formed was quantified by measuring its
A434 value.
Enzymatic reactions were also detected and quantified by high
performance liquid chromatography. The reaction mixture (800-µl total
volume) contained 50 mM MOPS buffer, pH 7.0, 1 mM NADH, 0.4 mM FeSO4, 1 mM biphenyl or 3 mM toluene as the substrates, and 40-840 µg of each enzyme component. The reaction was initiated by adding the substrate, and the reaction mixtures were incubated at
37 °C. At appropriate intervals, 150 µl of the reaction mixture was removed, then added to 300 µl of methanol in a microtube. After centrifugation for 10 min, 40 µl of the supernatant was injected into an Ultrasphere ODS column (Beckman) that had been equilibrated with water:methanol:acetonitrile (40:30:30, v/v). The
column was eluted for 6 min at 0.75 ml/min with the same solvent system, followed by elution with methanol:acetonitrile (45:55, v/v) for
20 min. The activity was evaluated from the substrate disappearance
measurement by detection at 254 nm for biphenyl and at 260 nm for toluene.
Kinetic Analysis
Steady-state kinetic parameters for TCE, cis-DCE,
trans-DCE, and 1,1-DCE were determined with purified ISP,
FDBphA3, and FDRBphA4. Two milliliters of the
reaction mixture containing 2.2~3.2 µM ISP, 26~38
µM FDBphA3, 2.2~3.2 µM
FDRBphA4, 20 µM ferrous ammonium sulfate, and
50 mM MOPS buffer (pH 7.0) was added to a glass vial (20 ml), which was sealed with a rubber septum and an aluminum crimp seal.
Chloroethylenes dissolved in
N,N-dimethylformamide were added to the vial and
preincubated at 30 °C for 30 min to allow equilibration of the
chloroethylene between the gas and liquid phases. The reaction was
initiated by the addition of 0.8 mM NADH, and incubation
was carried out with shaking at 30 °C for 10 min. The amounts of the
chloroethylenes in the gas phase were measured by gas chromatographic
analysis according to a previously described method (13), and those in
the aqueous phase were calculated according to Henry's Law constants
for the chloroethylenes (24). The values of Vmax
and Km were determined using the Hanes-Woolf (S/V S plot) analysis.
General Analytical Procedure
Purified ISP comprised of and subunits was subjected to
native PAGE. The mobilities of the ISP on 5%, 7.5%, 10%, and 12.5% acrylamide gels were treated with the Ferguson plot (25) to estimate
the molecular mass. SDS-PAGE was carried out according to the method of
Laemmli (26). The protein concentration was measured by a Bio-Rad
protein assay using bovine serum albumin as the standard.
 |
RESULTS |
Expression of ISP, FDBphA3, and
FDRBphA4--
The and subunits of ISP were
successfully coexpressed in E. coli using pUC-A1A2,
pUC-C1A2, and pHSG-C1C2 (Table I). In these expression systems, a lac promoter was applied to
induce the ISP and was sufficient to produce soluble ISP.
ISPBphA1A2 and ISPTodC1BphA2 were produced as
the soluble and active forms in the recombinant E. coli at
37 °C. When ISPTodC1C2 was expressed in E. coli using a recombinant plasmid carrying the original
todC1C2 genes, the level of expression of the subunit
was extremely low, as compared with that of the subunit. Therefore,
the Shine-Dalgarno sequence of todC2 was replaced by that of
bphA1, and the pHSG-C1C2 was finally constructed. The
recombinant E. coli cells carrying pHSG-C1C2 produced TodC2
with amounts equivalent to TodC1. However, the proteins were produced
as prominent inclusion bodies. A reduction of the cultivation
temperature from 37 °C to 30 °C resulted in an elevated yield of
the soluble ISP. FDBphA3 and FDRBphA4 were expressed as fusion proteins to facilitate protein purification and
solubilization. Recombinant E. coli cells carrying pET32-A3 under the control of a strong T7 promoter produced the soluble FDBphA3 fusion protein with the N-terminal TRX, His-tag,
and C-terminal His-tag with a molecular mass of 36 kDa (Fig.
1). As in the case of
FDBphA3, the bphA4 gene was also expressed as a
fusion protein with the N-terminal TRX and His-tag. However, the
FDRBphA4 fusion protein with a molecular mass of 63 kDa was
produced in E. coli (pET32-A4) as prominent inclusion
bodies. Replacement of the T7 promoter by the lac promoter
resulted in increased amounts of the soluble FDRBphA4
fusion protein. In addition, coexpression of a chaperone, GroELS of
E. coli using pKY206, allowed the FDRBphA4 fusion protein to efficiently solubilize. By using this coexpression system, the production of the FDRBphA4 fusion protein was
improved to 4.5-fold compared with that without pKY206.

View larger version (108K):
[in this window]
[in a new window]
|
Fig. 1.
SDS-PAGE of ISP, FD, and FDR fusion
proteins. Proteins were separated on 10% polyacrylamide gel and
stained with Coomassie Brilliant Blue. Lane 1, mass marker
proteins; lane 2, ISPBphA1A2; lane 3,
ISPTodC1BphA2; lane 4, ISPTodC1C2;
lane 5, FD BphA3 fusion protein; lane
6, FDR BphA4 fusion protein.
|
|
The catalytically active components of ISPs, FDBphA3 and
FDRBphA4, were purified as shown in Fig. 1. The yields of
the purified ISPBphA1A2, ISPTodC1BphA2,
ISPTodC1C2, FDBphA3, and FDRBphA4
from a 1-liter culture were 11.0, 9.4, 8.6, 22.1, and 20.4 mg, respectively.
Reconstitution of Dox Components--
The Dox activity was
observed when all purified components of ISP, FDBphA3, and
FDRBphA4 were mixed, indicating that all components were
successfully associated with one another in vitro. The
maximum activity of the hybrid enzyme was observed when 12-fold excess of FDBphA3 was incubated with ISPTodC1BphA2 and
FDRBphA4. Only 17%, 30%, and 70% of the maximum activity
was observed when 3-, 6-, and 9-folds excess of FDBphA3
were added, respectively (data not shown). The maximum activities of
the parental BphDox and TolDox were also observed in the presence of
15- and 12-fold excesses of FDBphA3,
respectively. The specific activities of the purified ISP
were determined in the presence of excess amounts of
FDbphA3 by high performance liquid chromatography analysis
and were evaluated from the rate of substrate depletion (Table
II). The specific activity of the hybrid
Dox toward biphenyl was 5.3 nmol/min/nmol ISP, which was comparable to
that of TolDox and was as low as 2.9% of that of BphDox. The specific
activity of the hybrid Dox toward toluene was 270.3 nmol/min/nmol ISP,
which was 7- and 1.5-fold higher than that of BphDox and TolDox,
respectively.
Subunit Conformation of Rieske Oxygenase--
Rieske non-heme iron
oxygenase (ISP) systems that are involved in the initial dioxygenation
of aromatic compounds and which comprise heteromeric subunits are
generally present as heterohexamer ( 3 3)
or heterotetramer ( 2 2) conformations
(27). The and subunits of the parental ISPBphA1A2,
ISPTodC1C2, and hybrid ISPTodC1BphA2 were
copurified by column chromatographies, indicating that these two
subunits were tightly associated with each other and formed the
catalytically active ISP (Fig. 1). An analysis of the purified ISP on
SDS-PAGE demonstrated that the and subunits were associated
with a 1:1 stoichiometry. To investigate how the purified subunits are
organized in ISP, nondenaturing PAGE was carried out with the purified
ISP. The hybrid ISPTodC1BphA2 as well as the parental
ISPBphA1A2 and ISPTodC1C2 were separated on
various concentrations of acrylamide gel, and the relative mobilities
were determined with the various concentrations. Based on the Ferguson
plot, the molecular masses of ISPBphA1A2,
ISPTodC1C2, and ISPTodC1BphA2 were estimated to
be 209, 160, and 229 kDa, respectively (Fig.
2). Because the theoretical molecular
mass of ISPBphA1A2 is 219 kDa for
3 3 and 146 kDa for
2 2, the parental ISPBphA1A2
is present as a heterohexamer. The theoretical molecular mass of
ISPTodC1C2 is 222 kDa for 3 3
and 148 kDa for 2 2, therefore, ISPTodC1C2 is present as a heterotetramer, which is in
agreement with the result reported by Subramanian et al.
(28). The ISPTodC1BphA2 hybrid has a similar conformation
to ISPBphA1A2, and the estimated molecular mass of 229 kDa
is in good agreement with the theoretical 226.5 kDa of
3 3 conformation.

View larger version (31K):
[in this window]
[in a new window]
|
Fig. 2.
Ferguson plots for estimation of molecular
masses of ISPBphA1A2, ISPTodC1C2, and
ISPTodC1BphA2 by native PAGE using various concentrations
of acrylamide gels. Purified ISP consisting of the and subunits was subjected to native PAGE using chicken egg white albumin
monomer (45 kDa), bovine serum albumin dimer (132 kDa), urease monomer
(272 kDa), and urease dimer (544 kDa) as mass standard proteins. The
mobilities of ISP on 5%, 7.5%, 10%, and 12.5% acrylamide gels were
treated using the Ferguson plot as follows. The relative mobilities
(Rf) of the standard proteins were determined at
four different gel concentrations (%T) and plotted as
logRf versus %T. The slope of
Kr was determined using linear regression of the %T logRf plot. The log (molecular mass of the
standards) was then plotted versus
logKr. The resultant equation, log (molecular mass of the
standards) = 1.9321 logKr 7.0181 (r = 0.99479), was used to estimate the molecular mass
of the ISP.
|
|
Kinetic Parameters of Hybrid Dox for Chloroethylenes--
Because
the parental BphDox is inactive toward chloroethylenes, the
steady-state kinetic parameters for TCE, cis-DCE,
trans-DCE, and 1,1-DCE were determined with purified TolDox
and hybrid Dox (Table III). The apparent
molecular activity (k0) of the hybrid Dox for
TCE is comparable to that of TolDox. Because conformation of TolDox and
hybrid Dox are 2 2 heterotetramer and
3 3 heterohexamer, respectively, the
catalytic center activity (kcat) of the hybrid Dox is calculated to be 1.4 min 1 site 1 and
33% lower than that of TolDox. The Km value for TCE
of the hybrid Dox is 130 µM, which is smaller than that
of TolDox (250 µM). The resulting catalytic efficiency,
kcat/Km value for TCE
increased 24% for the hybrid Dox, as compared with that for TolDox.
For the other chloroethylenes such as cis-DCE and 1,1-DCE,
the kcat values are higher in TolDox and the
Km values are smaller in the hybrid Dox. The results
indicate that the hybrid Dox acquired higher affinities for a variety
of chloroethylenes than the parental TolDox and that the catalytic
efficiency is slightly higher in the hybrid Dox. For the
trans-DCE, the hybrid Dox showed only a weak activity, and
thus the kinetic parameter with a high regression coefficient could not
be determined from the Hanes-Woolf plot.
Components Responsible for Enzyme Inactivation Coupled to TCE
Degradation--
It is known that TolDox is irreversibly inactivated
by coupling to TCE oxygenation (20). The hybrid Dox was also gradually inactivated during TCE oxygenation and was completely inactivated after
7.5 h of incubation (Fig. 3). To
identify the components responsible for being inactivated,
ISPTodC1BphA2, FDBphA3, or FDBphA4
was, respectively, added to the inactivated reaction mixture. The
addition of ISPTodC1BphA2 permitted the immediate
restoration of the enzymatic activity of the TCE oxygenation (Fig. 3).
On the other hand, the addition of FDBphA3 or
FDBphA4 failed to restore the activity. These results
indicate that the ISPTodC1BphA2 component is susceptible
and involved in the inactivation of the hybrid Dox during TCE
degradation.

View larger version (16K):
[in this window]
[in a new window]
|
Fig. 3.
Components responsible for enzyme
inactivation coupled to TCE degradation. A, the
reaction mixture containing 3.5 µM
ISPTodC1BphA2, 102 µM FDBphA3,
3.5 µM FDRBphA4, 20 µM ferrous
ammonium sulfate, 6.4 mM NADH, and 1 mM TCE in
50 mM Mops, pH 7.0, was incubated with shaking at 30 °C
for 7.5 h to allow complete inactivation of the enzyme. 1 mM TCE and 1 mM NADH were added to the reaction
mixture and further incubated for 2.5 h to confirm inactivation of
the enzyme. B, ISPTodC1BphA2,
FDBphA3, and FDRBphA4 were then added,
respectively, to the reaction mixture to recover the Dox
activity. Symbols: A, residual amounts of TCE
(open square); B, additions of none (open
triangle), ISPTodC1BphA2 (closed
square), FDBphA3 (closed circle), and
FDRBphA4 (closed diamond).
|
|
 |
DISCUSSION |
It is of great interest to construct microorganisms with enhanced
and expanded degradation capabilities for environmental pollutants.
Some attempts, including in vitro DNA shuffling, domain exchanges, and subunit exchanges have been achieved for structural remodeling of dioxygenases with minimum prior information about the
enzymes (4-9, 29). We previously reported that recombinant bacteria
producing hybrid TodC1-BphA2A3A4 dioxygenase constructed by subunit
exchanges, exhibited the expanded capability of converting various
aromatic compounds (21, 30) and the enhanced degradation activity
toward TCE (13, 30).
To reconstitute ISP, we first mixed in vitro and subunits of BphDox, TolDox, and TodC1-BphA2 hybrid Dox that had been individually expressed in E. coli but failed to reconstitute
ISP with high activity (data not shown). However, the ISP components of
BphDox and hybrid Dox were fully active when both subunits were
coexpressed in E. coli. This result is different from the previous work by Hurtubise et al. (31). They reported that
His-tagged and subunits of ISP from Comamonas
testosteroni were separately expressed in E. coli and
that the mixture of these subunits exhibited high activity.
It was found that the reconstituted Dox with purified ISP,
FDBphA3, and FDRBphA4 are highly functional,
indicating that FDBphA3 and FDRBphA4
originating from BphDox interacted with a foreign ISP that originated
from TolDox and hybrid Dox, where an electron from NADH is transferred
to the Rieske [2Fe-2S] center of the subunit. The reduced ISP
activates molecular oxygen and introduces it to the
substrates. The maximum activity of ISP was observed when more than
12-fold equivalents of FDBphA3 were incubated with ISP and
FDRBphA4. The recombinant FDBphA3 fusion
protein may be less active than the native FD due to the additional
fusion tags. It is also likely that relatively low activity of
FDBphA3 may be associated with the instability of this
protein. The FD of BphDox from C. testosteroni was also
reported to be labile (32).
The substrate specificities of the purified hybrid Dox were similar to
those of TolDox (Table II), indicating the subunit of ISP is
critically responsible for recognition of the substrates and the
catalytic activity. This result also implies that, in the hybrid Dox,
the structure of the functional domains such as the mononuclear
iron-binding residues and substrate binding pocket can be retained even
in the subunit conformation of an 3 3.
Changing the subunit conformation from 2 2
to 3 3 may lead to a small change in the
structure around the active site. The Km values of
the hybrid Dox for the chloroethylenes ranged from 130 to 370 µM (Table III). Those of the parental TolDox ranged from 250 to 824 µM (Table III). These results suggest that the
hybrid Dox gains slightly higher affinity for substrates used in this study than TolDox. A binding pocket around the active center of ISPTodC1BphA2 may be slightly relaxed to accommodate
various chloroethylenes. Although the k0 values
of the hybrid Dox are comparable to those of TolDox, the
kcat values of the hybrid Dox are slightly lower than those of TolDox. It is likely that the conformation of the catalytic residues involved in the mononuclear iron binding in ISPTodC1BphA2 is slightly changed compared with that in
ISPTodC1C2 (33). As previously reported (13), the
recombinant resting cells expressing hybrid Dox degraded TCE 3-fold
faster than those expressing TolDox. The TCE used in this experiment
was as low as 76 µM. Under conditions below the
Km value, the hybrid Dox is able to better exert
its higher activity than TolDox. Thus, the elevated activity of the
recombinant bacteria expressing the hybrid Dox toward TCE reflects the
elevated affinity of the hybrid Dox for TCE.
There are some reports on the irreversible inactivation of
monooxygenases (34) and dioxygenases (20, 35). Lee reported that
benzene dioxygenase was inactivated via the Fenton-type
reaction that formed hydroxyl radicals from the uncoupled reaction of
hydrogen peroxide with ferrous mononuclear iron at the catalytic center (35). Li and Wackett (20) reported that TolDox is inactivated via alkylation of the enzyme during TCE degradation. In this
study, an irreversibly inactivated component of the hybrid Dox was
determined to be ISP not FD or FDR (Fig. 3). Neither cleavage of the
peptide bond nor dissociation of the and subunits occurred on
ISPTodC1BphA2 during TCE oxygenation as judged by the
SDS-PAGE and native PAGE (data not shown). Some attempts to understand
the mechanism for the TCE inactivation of ISPTodC1BphA2
were carried out using chelating agents and catalase, indicating that
the hydroxyl radical caused by the Fenton reaction was not implicated
in the TCE inactivation of ISPTodC1BphA2 (data not shown).
Therefore, it is likely that the hybrid ISPTodC1BphA2 is
inactivated by a fashion similar to the ISP of TolDox (20).
 |
FOOTNOTES |
*
The costs of publication of this
article were defrayed in part by the
payment of page charges. The article
must therefore be hereby marked
"advertisement" in
accordance with 18 U.S.C. Section
1734 solely to indicate this fact.
To whom correspondence should be addressed: Laboratory of Applied
Microbiology, Dept. of Bioscience and Biotechnology, Faculty of
Agriculture, Kyushu University, Fukuoka 812-8581, Japan. Tel./Fax: 81-92-642-2849; E-mail address: kfurukaw@agr.kyushu-u.ac.jp.
Published, JBC Papers in Press, June 4, 2001, DOI 10.1074/jbc.M102025200
 |
ABBREVIATIONS |
The abbreviations used are:
BphDox, biphenyl
dioxygenase;
PCB, polychlorinated biphenyl;
ISP, iron-sulfur protein;
FD, ferredoxin;
FDR, ferredoxin reductase;
TolDox, toluene dioxygenase;
TCE, trichloroethylene;
PCR, polymerase chain reaction;
TRX, thioredoxin gene;
MOPS, 4-morpholinepropanesulfonic acid;
MEG, 50
mM MOPS buffer, pH 7.0, containing 5% ethanol and 5%
glycerol;
DCE, dichloroethylene;
KP, 10 mM potassium
phosphate buffer, pH 7.0;
PAGE, polyacrylamide gel
electrophoresis.
 |
REFERENCES |
| 1.
|
Taira, K.,
Hirose, J.,
Hayashida, S.,
and Furukawa, K.
(1992)
J. Biol. Chem.
267,
4844-4853
|
| 2.
|
Gibson, D. T.,
and Parales, R. E.
(2000)
Curr. Opin. Biotechnol.
11,
236-243
|
| 3.
|
Furukawa, K.,
Hirose, J.,
Suyama, A.,
Zaiki, T.,
and Hayashida, S.
(1993)
J. Bacteriol.
175,
5224-5232
|
| 4.
|
Erickson, B. D.,
and Mondello, F. J.
(1993)
Appl. Environ. Microbiol.
59,
3858-3862
|
| 5.
|
Mondello, F. J.,
Turcich, M. P.,
Lobos, J. H.,
and Erickson, B. D.
(1997)
Appl. Environ. Microbiol.
63,
3096-3103
|
| 6.
|
Kimura, N.,
Nishi, A.,
Goto, M.,
and Furukawa, K.
(1997)
J. Bacteriol.
179,
3936-3943
|
| 7.
|
Kumamaru, T.,
Suenaga, H.,
Mitsuoka, M.,
Watanabe, T.,
and Furukawa, K.
(1998)
Nat. Biotechnol.
16,
663-666
|
| 8.
|
Suenaga, H.,
Goto, M.,
and Furukawa, K.
(2001)
J. Biol. Chem.
276,
22500-22506
|
| 9.
|
Furukawa, K.
(2000)
Curr. Opin. Biotechnol.
11,
244-249
|
| 10.
|
Gibson, D. T.,
Cruden, D. L.,
Haddock, J. D.,
Zylstra, G. J.,
and Brand, J. M.
(1993)
J. Bacteriol.
175,
4561-4564
|
| 11.
|
Wackett, L. P.,
and Gibson, D. T.
(1988)
Appl. Environ. Microbiol.
54,
1703-1708
|
| 12.
|
Zylstra, G. J.,
and Gibson, D. T.
(1989)
J. Biol. Chem.
264,
14940-14946
|
| 13.
|
Furukawa, K.,
Hirose, J.,
Hayashida, S.,
and Nakamura, K.
(1994)
J. Bacteriol.
176,
2121-2123
|
| 14.
| U. S. Environmental Protection Agency (1985) Document NPL-U3-6-3.
US
|
| 15.
|
Infante, P. F.,
and Tsongas, T. A.
(1982)
Environ. Sci. Res.
25,
301-327
|
| 16.
|
Little, C. D.,
Palumbo, A. V.,
Herbes, S. E.,
Lidstrom, M. E.,
Tyndall, R. L.,
and Gilmer, P. J.
(1988)
Appl. Environ. Microbiol.
54,
951-956
|
| 17.
|
Shields, M. S.,
Montgomery, S. O.,
Cuskey, S. M.,
Chapman, P. J.,
and Pritchard, P. H.
(1991)
Appl. Environ. Microbiol.
57,
1935-1941
|
| 18.
|
Arciero, D.,
Vannelli, T.,
Logan, M.,
and Hooper, A. B.
(1989)
Biochem. Biophys. Res. Commun.
159,
640-643
|
| 19.
|
Nelson, M. J.,
Montgomery, S. O.,
Mahaffey, W. R.,
and Pritchard, P. H.
(1987)
Appl. Environ. Microbiol.
53,
949-954
|
| 20.
|
Li, S.,
and Wackett, L. P.
(1992)
Biochem. Biophys. Res. Commun.
185,
443-451
|
| 21.
|
Hirose, J.,
Suyama, A.,
Hayashida, S.,
and Furukawa, K.
(1994)
Gene
138,
27-33
|
| 22.
|
Ashiuchi, M.,
Yoshimura, T.,
Kitamura, T.,
Kawata, Y.,
Nagai, J.,
Gorlatov, S.,
Esaki, N.,
and Soda, K.
(1995)
J. Biochem.
117,
495-498
|
| 23.
|
Haddock, J. D.,
and Gibson, D. T.
(1995)
J. Bacteriol.
177,
5834-5839
|
| 24.
|
Gossett, J. M.
(1987)
Environ. Sci. Technol.
21,
202-208
|
| 25.
| Gallagher, S. R. (1995) in Current Protocols in Protein
Science (Coligan, J. E., Dunn, B. M., Ploegh, H. L., Speicher, D. W., and Wingfield, P. T., eds) Unit
10.3.5-10.3.11, John Wiley & Sons, New York
|
| 26.
|
Laemmli, U. K.
(1970)
Nature
227,
680-685
|
| 27.
|
Maison, J. R.,
and Cammack, R.
(1992)
Annu. Rev. Microbiol.
46,
277-305
|
| 28.
|
Subramanian, V.,
Liu, T. N.,
Yeh, W. K.,
and Gibson, D. T.
(1979)
Biochem. Biophys. Res. Commun.
91,
1131-1139
|
| 29.
|
Bruhlmann, F.,
and Chen, W.
(1999)
Biotech. Bioeng.
63,
544-551
|
| 30.
|
Suyama, A.,
Iwakiri, R.,
Kimura, N.,
Nishi, A.,
Nakamura, K.,
and Furukawa, K.
(1996)
J. Bacteriol.
178,
4039-4046
|
| 31.
|
Hurtubise, Y.,
Barriault, D.,
and Sylvestre, M.
(1996)
J. Biol. Chem.
271,
8152-8156
|
| 32.
|
Hurtubise, Y.,
Barriault, D.,
Powlowski, J.,
and Sylvestre, M.
(1995)
J. Bacteriol.
177,
6610-6618
|
| 33.
|
Jiang, H.,
Parales, R. E.,
Lynch, N. A.,
and Gibson, D. T.
(1996)
J. Bacteriol.
178,
3133-3139
|
| 34.
|
Newman, L. M.,
and Wackett, L. P.
(1997)
J. Bacteriol.
179,
90-96
|
| 35.
|
Lee, K.
(1999)
J. Bacteriol.
181,
2719-2725
|
Copyright © 2001 by The American Society for Biochemistry and Molecular Biology, Inc.

CiteULike Complore Connotea Del.icio.us Digg Reddit Technorati What's this?
This article has been cited by other articles:

|
 |

|
 |
 
E. R. Goncalves, H. Hara, D. Miyazawa, J. E. Davies, L. D. Eltis, and W. W. Mohn
Transcriptomic Assessment of Isozymes in the Biphenyl Pathway of Rhodococcus sp. Strain RHA1
Appl. Envir. Microbiol.,
September 1, 2006;
72(9):
6183 - 6193.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C. Bagneris, R. Cammack, and J. R. Mason
Subtle Difference between Benzene and Toluene Dioxygenases of Pseudomonas putida
Appl. Envir. Microbiol.,
March 1, 2005;
71(3):
1570 - 1580.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
K. Furukawa, H. Suenaga, and M. Goto
Biphenyl Dioxygenases: Functional Versatilities and Directed Evolution
J. Bacteriol.,
August 15, 2004;
186(16):
5189 - 5196.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. D. Van Hamme, A. Singh, and O. P. Ward
Recent Advances in Petroleum Microbiology
Microbiol. Mol. Biol. Rev.,
December 1, 2003;
67(4):
503 - 549.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
Y. Ge and L. D. Eltis
Characterization of Hybrid Toluate and Benzoate Dioxygenases
J. Bacteriol.,
September 15, 2003;
185(18):
5333 - 5341.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
Y. Ge, F. H. Vaillancourt, N. Y. R. Agar, and L. D. Eltis
Reactivity of Toluate Dioxygenase with Substituted Benzoates and Dioxygen
J. Bacteriol.,
August 1, 2002;
184(15):
4096 - 4103.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
H. Suenaga, T. Watanabe, M. Sato, Ngadiman, and K. Furukawa
Alteration of Regiospecificity in Biphenyl Dioxygenase by Active-Site Engineering
J. Bacteriol.,
July 1, 2002;
184(13):
3682 - 3688.
[Abstract]
[Full Text]
[PDF]
|
 |
|
Copyright © 2001 by the American Society for Biochemistry and Molecular Biology.
|
Advertisement
Advertisement
|